CS208196B2 - Method of making the perorally applicable preparation with the retarded liberation of the cefalexine as the active component - Google Patents
Method of making the perorally applicable preparation with the retarded liberation of the cefalexine as the active component Download PDFInfo
- Publication number
- CS208196B2 CS208196B2 CS773167A CS316777A CS208196B2 CS 208196 B2 CS208196 B2 CS 208196B2 CS 773167 A CS773167 A CS 773167A CS 316777 A CS316777 A CS 316777A CS 208196 B2 CS208196 B2 CS 208196B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- cefalexin
- hours
- cephalexin
- composition
- coated
- Prior art date
Links
- 0 CC(C[C@](CC=C)O)(C(*)C(C(C)=C)N)[Cn] Chemical compound CC(C[C@](CC=C)O)(C(*)C(C(C)=C)N)[Cn] 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5492576A JPS52139713A (en) | 1976-05-13 | 1976-05-13 | Sustained release cefalexin preparations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS208196B2 true CS208196B2 (en) | 1981-08-31 |
Family
ID=12984185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS773167A CS208196B2 (en) | 1976-05-13 | 1977-05-13 | Method of making the perorally applicable preparation with the retarded liberation of the cefalexine as the active component |
Country Status (27)
| Country | Link |
|---|---|
| JP (1) | JPS52139713A (nl) |
| AR (1) | AR224494A1 (nl) |
| AT (1) | AT351159B (nl) |
| AU (1) | AU508793B2 (nl) |
| BE (1) | BE854640A (nl) |
| CA (1) | CA1085296A (nl) |
| CS (1) | CS208196B2 (nl) |
| DD (1) | DD132232A5 (nl) |
| DE (1) | DE2721785A1 (nl) |
| DK (1) | DK208077A (nl) |
| ES (1) | ES458710A1 (nl) |
| FI (1) | FI771491A (nl) |
| FR (1) | FR2350836A1 (nl) |
| GB (1) | GB1543543A (nl) |
| GR (1) | GR68895B (nl) |
| HU (1) | HU184196B (nl) |
| IE (1) | IE45415B1 (nl) |
| IL (1) | IL52075A (nl) |
| MX (1) | MX5976E (nl) |
| NL (1) | NL7704879A (nl) |
| NZ (1) | NZ183927A (nl) |
| PL (1) | PL111183B1 (nl) |
| PT (1) | PT66514B (nl) |
| RO (1) | RO72935A (nl) |
| SE (1) | SE426780B (nl) |
| SU (1) | SU1218919A3 (nl) |
| ZA (1) | ZA772757B (nl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5545601A (en) * | 1978-09-26 | 1980-03-31 | Toyo Jozo Co Ltd | Long-acting cephalexin and its preparation |
| FR2453639A1 (fr) * | 1979-04-09 | 1980-11-07 | Sanofi Sa | Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl |
| JPS5659707A (en) * | 1979-10-19 | 1981-05-23 | Toyo Jozo Co Ltd | Lasting antibiotic pharmaceutical and its preparation |
| JPS5826816A (ja) * | 1981-08-11 | 1983-02-17 | Teisan Seiyaku Kk | 球形顆粒からなる持続性複合顆粒剤 |
| JPS5846019A (ja) * | 1981-09-14 | 1983-03-17 | Kanebo Ltd | 持続性ニフエジピン製剤 |
| JPS5883613A (ja) * | 1981-11-10 | 1983-05-19 | Toa Eiyou Kagaku Kogyo Kk | 硝酸イソソルビト−ル製剤 |
| JPS5883106U (ja) * | 1981-11-30 | 1983-06-06 | 松下電工株式会社 | 電磁石装置に於けるオイルダツシユポツト |
| US4525339A (en) * | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
| JPS601128A (ja) * | 1983-06-15 | 1985-01-07 | Shionogi & Co Ltd | 作用持続型セフアクロル製剤 |
| JPS6144811A (ja) * | 1984-08-10 | 1986-03-04 | Ss Pharmaceut Co Ltd | 徐放性ジクロフエナクナトリウム製剤 |
| FR2577800B1 (fr) * | 1985-02-22 | 1990-09-07 | Grimberg Georges | Medicament sous forme galenique gastro-resistante |
| JPS62226926A (ja) * | 1986-03-27 | 1987-10-05 | Teisan Seiyaku Kk | 持続性複合顆粒剤 |
| AU2006235483B2 (en) * | 2005-04-12 | 2010-11-25 | Elan Pharma International Limited | Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection |
| CN114617855A (zh) * | 2020-12-14 | 2022-06-14 | 江苏贝佳制药有限公司 | 头孢氨苄胶囊的制备方法 |
-
1976
- 1976-05-13 JP JP5492576A patent/JPS52139713A/ja active Granted
-
1977
- 1977-04-20 CA CA276,514A patent/CA1085296A/en not_active Expired
- 1977-04-26 NZ NZ183927A patent/NZ183927A/xx unknown
- 1977-05-03 NL NL7704879A patent/NL7704879A/nl active Search and Examination
- 1977-05-05 PT PT66514A patent/PT66514B/pt unknown
- 1977-05-09 IE IE940/77A patent/IE45415B1/en unknown
- 1977-05-09 ZA ZA00772757A patent/ZA772757B/xx unknown
- 1977-05-11 FI FI771491A patent/FI771491A/fi not_active Application Discontinuation
- 1977-05-11 GB GB19853/77A patent/GB1543543A/en not_active Expired
- 1977-05-11 SE SE7705502A patent/SE426780B/xx not_active IP Right Cessation
- 1977-05-11 DK DK208077A patent/DK208077A/da not_active Application Discontinuation
- 1977-05-11 AU AU25078/77A patent/AU508793B2/en not_active Expired
- 1977-05-11 ES ES458710A patent/ES458710A1/es not_active Expired
- 1977-05-12 RO RO7790312A patent/RO72935A/ro unknown
- 1977-05-12 HU HU77SI1575A patent/HU184196B/hu unknown
- 1977-05-12 GR GR53444A patent/GR68895B/el unknown
- 1977-05-12 PL PL1977198058A patent/PL111183B1/pl unknown
- 1977-05-12 MX MX775739U patent/MX5976E/es unknown
- 1977-05-12 SU SU772485596A patent/SU1218919A3/ru active
- 1977-05-12 FR FR7714616A patent/FR2350836A1/fr active Granted
- 1977-05-12 IL IL52075A patent/IL52075A/xx unknown
- 1977-05-12 AT AT341877A patent/AT351159B/de not_active IP Right Cessation
- 1977-05-13 CS CS773167A patent/CS208196B2/cs unknown
- 1977-05-13 BE BE177585A patent/BE854640A/xx unknown
- 1977-05-13 AR AR267621A patent/AR224494A1/es active
- 1977-05-13 DD DD7700198922A patent/DD132232A5/xx unknown
- 1977-05-13 DE DE19772721785 patent/DE2721785A1/de active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| IL52075A (en) | 1980-06-30 |
| AU2507877A (en) | 1978-11-16 |
| PT66514B (en) | 1978-10-16 |
| FI771491A (nl) | 1977-11-14 |
| JPS5547611B2 (nl) | 1980-12-01 |
| DE2721785A1 (de) | 1977-11-24 |
| AU508793B2 (en) | 1980-04-03 |
| GB1543543A (en) | 1979-04-04 |
| PL198058A1 (pl) | 1979-03-26 |
| BE854640A (fr) | 1977-09-01 |
| IL52075A0 (en) | 1977-07-31 |
| ES458710A1 (es) | 1978-03-01 |
| SE7705502L (sv) | 1977-11-14 |
| IE45415L (en) | 1977-11-13 |
| MX5976E (es) | 1984-09-12 |
| IE45415B1 (en) | 1982-08-25 |
| RO72935A (ro) | 1982-07-06 |
| PT66514A (en) | 1977-06-01 |
| JPS52139713A (en) | 1977-11-21 |
| SE426780B (sv) | 1983-02-14 |
| AR224494A1 (es) | 1981-12-15 |
| DE2721785C2 (nl) | 1989-03-16 |
| CA1085296A (en) | 1980-09-09 |
| NL7704879A (nl) | 1977-11-15 |
| HU184196B (en) | 1984-07-30 |
| ATA341877A (de) | 1978-12-15 |
| AT351159B (de) | 1979-07-10 |
| SU1218919A3 (ru) | 1986-03-15 |
| DK208077A (da) | 1977-11-14 |
| FR2350836B1 (nl) | 1981-02-06 |
| NZ183927A (en) | 1980-02-21 |
| GR68895B (nl) | 1982-03-15 |
| FR2350836A1 (fr) | 1977-12-09 |
| PL111183B1 (en) | 1980-08-30 |
| ZA772757B (en) | 1978-04-26 |
| DD132232A5 (de) | 1978-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2681315C2 (ru) | Лекарственные формы для пероральной доставки адсорбентов в кишечник | |
| US4250166A (en) | Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin | |
| US5294448A (en) | Delayed release formulations | |
| US8007827B2 (en) | Pharmaceutical dosage forms having immediate release and/or controlled release properties | |
| US6638532B2 (en) | Tetracycline—doxycycline antibiotic composition | |
| US6610328B2 (en) | Amoxicillin-clarithromycin antibiotic composition | |
| EP1318792B1 (en) | Sustained release composition containing clarithromycin | |
| US20040018234A1 (en) | Antibiotic composition | |
| CS208196B2 (en) | Method of making the perorally applicable preparation with the retarded liberation of the cefalexine as the active component | |
| US6627222B2 (en) | Amoxicillin-dicloxacillin antibiotic composition | |
| US6623758B2 (en) | Cephalosporin-metronidazole antibiotic composition | |
| US20120058936A1 (en) | Compositions and methods for elimination of gram negative bacteria | |
| US8357394B2 (en) | Compositions and methods for improved efficacy of penicillin-type antibiotics | |
| US6632453B2 (en) | Ciprofoxacin-metronidazole antibiotic composition | |
| US8361506B2 (en) | Fast release dosage forms for antibiotics | |
| CZ20001076A3 (cs) | Léčivo s regulovaným uvolněním aktivní sloučeniny | |
| US20080139526A1 (en) | Modified release dosage forms of amoxicillin | |
| CA2478121A1 (en) | Antibiotic composition | |
| WO2020048979A1 (en) | Controlled drug release formulation | |
| MX2008004282A (en) | Pharmaceutical dosage forms having immediate release and/orcontrolled release properties | |
| SI21601A (sl) | Terapevtski sistem | |
| JP2010511607A (ja) | 変性放出アモキシシリン製剤 |